|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02677 DISTINCT HEALTH
Nominal 
24.460 -0.420 (-1.688%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 595,909 | 17.013% | 1,064,529 | 958,578 | 690,435 | 473,184 |
| Cost of Sales | (433,510) | 10.116% | (797,489) | (732,575) | (556,933) | (429,204) |
| Gross Profit | 162,399 | 40.505% | 267,040 | 226,003 | 133,502 | 43,980 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 66,853 | -13.301% | 116,250 | 133,505 | (289,585) | (87,470) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (143) | 0 | 0 | |
| Profit / (Loss) before Taxation | 92,364 | 23.984% | 135,927 | 79,744 | (362,194) | (239,332) | |
| Taxation | (8,974) | -- | (4,478) | 483 | 8,949 | 17,810 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,732 | 44.857% | 3,615 | 3,578 | 2,576 | 6,026 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 86,122 | 11.336% | 135,064 | 83,805 | (350,669) | (215,496) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,432 | -72.874% | 10,034 | 8,023 | 5,896 | 14,375 |
| Depreciation & Amortisation | 64,960 | -3.881% | 132,928 | 135,835 | 127,067 | 111,123 |
| Directors' Emoluments | -- | -- | 3,553 | 6,532 | 4,291 | 1,943 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 171.000 | -69.189% | 968.000 | 601.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 15.143 | 12.282 | -- | -- |
| NBV per share ($) | 13.581 | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 21/08/2026 13:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 86,122 |
| %Change | 11.336% |
| EPS / (LPS) | RMB 1.710 |
| NBV Per Share (¥) | RMB 13.581 |